Coya Therapeutics (NASDAQ:COYA) Stock Rating Reaffirmed by Chardan Capital themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $11.68 on Monday. The stock’s 50-day moving average is $13.73 and its two-hundred day […]
Freeport-McMoRan Inc. (NYSE:FCX – Get Free Report) VP Douglas N. Currault II sold 55,000 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $51.99, for a total value of $2,859,450.00. Following the completion of the sale, the vice president now directly […]
Chardan Capital reissued their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Free Report) in a research note released on Monday, Benzinga reports. Chardan Capital currently has a $14.00 price objective on the stock. Coya Therapeutics Trading Down 3.6 % Shares of NASDAQ:COYA opened at $8.72 on Monday. The stock has a market capitalization […]
Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five research firms that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 […]